...
Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making.

MD MRCGP DFFP
Was this answer helpful?
Authored and medically reviewed by Dr Farzana Khan on 28 July 2026
Rate Dr Farzana's explanation



Assessment first


UK guidance


Safety focused

Women’s Health Clinic FAQ

What is the risk of developing de novo urge incontinence or overactive bladder after mid-urethral sling placement?

Surgical choices for stress urinary incontinence can feel difficult because benefit, recovery, mesh considerations and complication pathways all matter. The safest answer starts with the exact symptom pattern and the reason surgery is being considered.

Direct answer

New urgency or overactive bladder symptoms can occur after mid-urethral sling placement, although the risk varies between patients and studies. Symptoms may be related to bladder sensitivity, infection, incomplete emptying, obstruction, pre-existing mixed incontinence or post-operative irritation. The important point is not to assume every leak after surgery is stress leakage. New urgency, frequency, pain or poor stream should be assessed.

A good consultation should separate stress leakage from urgency, retention, infection, pain, prolapse and previous-surgery issues before recommending a procedure or revision pathway.


Educational only. This page is educational and does not replace individual assessment. Results vary. Not a cure.

Women's Health Clinic SUI consultation for What is the risk of developing de novo urge incontinence or overactive bladder after mid-urethral sling placement?

SUI surgery guidance

At a glance

These points help orient the decision before a surgical or specialist continence consultation.

At a glance

Clinical summary

Recovery

Advice depends on healing, symptoms and procedure type.

Risks

Urgency, pain, infection or retention should be reviewed.

Personal factors

Work, lifting, BMI and tissue health can change advice.

Follow-up

Return to activity should be guided by the treating team.

Important safety note

Seek medical advice promptly for inability to pass urine, painful bladder fullness, fever, blood in urine, severe pelvic or groin pain, unusual vaginal bleeding or discharge, suspected mesh exposure, recurrent infection symptoms or new neurological symptoms.

SUI
Mesh
Recovery
Consent
Follow-up




Detailed answer

Detailed answer

Recovery after SUI surgery is not only about the calendar; it is also about bladder emptying, pain, vaginal healing and whether leakage or urgency changes.

Clinical context

Recovery advice should be personalised because healing, job demands, sex, lifting, urgency and bladder emptying do not follow one identical timetable.

Urethra
Bladder neck
Mesh safety
Aftercare

What the procedure is trying to change

Recovery after SUI surgery is not only about the calendar; it is also about bladder emptying, pain, vaginal healing and whether leakage or urgency changes.

Why the details matter

Activity, sex, lifting and work advice should come from the operating team because the procedure, tissues and patient context vary.

Guidance and evidence

New urgency, poor stream, painful fullness, fever, bleeding, discharge or worsening pelvic pain should not be treated as routine recovery.

Safety and follow-up

Long-term outcome discussions should be practical and non-stigmatising, especially when weight, occupation or previous symptoms affect risk.

What this means in practice

Responsible SUI information explains anatomy, material, recovery and complication pathways without teaching surgical technique.

If symptoms suggest retention, infection, mesh exposure, severe pain or new urgency, treatment decisions should pause until the cause is assessed.





Patient safety

Why this distinction matters

Sling route, mesh use, previous surgery, recovery symptoms and revision options can change both benefit and risk.

It clarifies anatomy

Retropubic, transobturator, fascial and colposuspension approaches are not the same operation.

It protects consent

Patients should understand alternatives, mesh-specific issues, removal limits and follow-up before surgery.

It separates symptoms

Stress leakage, urgency, retention, pain and infection can overlap but need different responses.

It prevents overclaiming

Surgery may help selected patients, but no procedure should be presented as certain, effortless or suitable for everyone.

A clinician-led decision

The safest plan balances symptom burden, diagnosis, previous treatment, tissue health, recovery needs, risks and patient priorities.

This is especially important when mesh, revision surgery, pain, retention or complex pelvic-floor symptoms are part of the picture.





Considerations

What to consider

Before deciding, consider diagnosis, non-surgical treatment history, urgency symptoms, emptying, prolapse, pain, previous surgery, recovery needs and who will manage complications.

Consultation priorities

The most useful aftercare plan tells the patient what to expect, what to avoid early on and which symptoms should trigger review.

Diagnosis
Alternatives
Recovery
Review

Before surgery

Before surgery, the team should explain expected recovery, restrictions, warning signs and who to contact after discharge.

Consent discussion

Early recovery focuses on passing urine, pain control, wound or vaginal healing and avoiding strain while tissues settle.

After surgery

Return to sex, work, exercise or heavy lifting should be paced according to written advice and symptom response.

If symptoms persist

If leakage returns or new symptoms appear, review should check stress leakage, urgency, infection, emptying and pain separately.

Practical expectations

Recovery and results vary; follow-up should review leakage, bladder emptying, pain, urgency, vaginal healing and any new symptoms.

Costs, availability, procedure type and aftercare details should be confirmed directly with the clinic before booking.





Common concerns and myths

Common misconceptions

These points keep surgical SUI decisions realistic and safety-led.

Myth: recovery rules are identical for everyone

Reality: timing depends on the procedure, tissue healing, symptoms, job demands and surgeon advice.

Myth: urgency after surgery proves failure

Reality: urgency can have several causes and should be assessed.

Myth: weight discussions should be avoided

Reality: weight can affect pressure and recurrence risk, but it should be discussed respectfully and clinically.

Evidence and guidance

Clinical recommendations should follow current guidance, patient-specific assessment and transparent discussion of evidence limits.

Alternatives

Supervised PFMT, pessary support, bulking, colposuspension, autologous fascial sling, mesh sling or specialist referral may fit different patients.





Safety checklist

Safety checklist

Use these checks before relying on a surgical, mesh or revision recommendation for SUI.

Is the diagnosis clear?

Stress leakage, urgency, overflow, infection, retention, pain and prolapse-related symptoms should be separated.

Are alternatives understood?

Ask how non-surgical care, bulking, colposuspension, fascial sling, mesh sling or specialist referral compare in your case.

Are red flags absent?

Seek medical advice promptly for inability to pass urine, painful bladder fullness, fever, blood in urine, severe pelvic or groin pain, unusual vaginal bleeding or discharge, suspected mesh exposure, recurrent infection symptoms or new neurological symptoms.

Is follow-up planned?

Know who reviews urinary retention, infection, pain, mesh exposure, new urgency or recurrent leakage after surgery.

Reassuring signs

Proceeding is more reasonable when diagnosis is clear, options are understood, expectations are realistic and follow-up is arranged.

Clear diagnosis
Informed consent
Review plan

Reasons to pause

Seek medical advice promptly for inability to pass urine, painful bladder fullness, fever, blood in urine, severe pelvic or groin pain, unusual vaginal bleeding or discharge, suspected mesh exposure, recurrent infection symptoms or new neurological symptoms.

Retention
Infection
Mesh concern




When to escalate

When to seek medical help

Some symptoms before or after SUI surgery need prompt review.

Use NHS 111 online

Unable to pass urine

Inability to pass urine, painful bladder fullness or repeated unsuccessful attempts to void need prompt clinical advice.

Infection symptoms

Fever, burning with systemic symptoms, worsening pelvic pain, discharge or feeling unwell should be assessed.

Pain, bleeding or mesh concern

Severe pelvic or groin pain, unusual vaginal bleeding, blood in urine or suspected mesh exposure should not be ignored.

Emergency symptoms

Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

More clinical detail

Recovery is symptom-led as well as time-led

Calendar timelines are helpful, but they should not override symptoms. Pain, fever, bleeding, discharge, inability to pass urine, poor stream or new urgency may change the recovery plan and should be discussed with the treating team.

Returning to activity

Work, sex, lifting and exercise advice depends on the procedure, healing, job demands, pelvic-floor support and whether leakage or pain returns. Written aftercare from the operating team should take priority over generic online timelines.

Next step

Book a continence consultation

A consultation can clarify the SUI mechanism, review conservative and surgical options, and decide whether specialist assessment is needed.

View Research Sources (12 Sources)
• Change in Overactive Bladder Symptoms After Surgery for Stress Urinary Incontinence in Women - PMC
• Comparison of tension-free transvaginal tape and transobturator tape in terms of urinary incontinence and quality of life among Turkish women - PMC
• Complications of mid urethral slings: important outcomes for future clinical trials - PubMed
• Current Role of Urethrolysis and Partial Excision in Patients Seeking Revision of Anti-Incontinence Sling - Department of Urology
• De novo or resolved urgency and urgency urinary incontinence after midurethral sling operations: How can we properly counsel our patients? - PMC
• De novo overactive bladder following midurethral sling procedures: a systematic review of the literature and meta-analysis - PubMed
• Do severe obese patients with stress urinary incontinence benefit from transobturator tape procedure? 3-year surgical outcome - PMC
• Efficacy of botulinum toxin in the management of refractory de novo overactive bladder symptoms in women after midurethral sling placement: retrospective, single center study - PMC
• Evaluation and management of voiding dysfunction after midurethral sling procedures
• Five-Year Follow-up in Patients with Transobturator Tape – A Retrospective Observational Study - PMC
• Full article: Risk Factor of De Novo Urgency and Urge Incontinence After Autologous Fascia Pubovaginal Sling - Taylor & Francis
• ICS 2023 Abstract 472 De novo overactive bladder after midurethral sling surgery:prevalence , timing and risk factors

These 12 source names are selected from 154 curated sources. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers, evidence reviews; duplicate and low-relevance records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.